ROBERT GARCIA: Open Payments
NPI 1184622136 · NORTHVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,996 in 254 payments from 23 companies in 2025. Trend: 2023 $3,735 · 2024 $4,319 · 2025 $4,996
Food & beverage: $4,824Education: $172
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 31 | $588 |
| ABBVIE INC. | 25 | $550 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $463 |
| Alkermes, Inc. | 18 | $460 |
| Otsuka America Pharmaceutical, Inc. | 19 | $448 |
| Neurocrine BioSciences, Inc. | 15 | $313 |
| Lundbeck LLC | 13 | $303 |
| Tris Pharma Inc | 10 | $254 |
| Teva Pharmaceuticals USA, Inc. | 8 | $230 |
| Validus Pharmaceuticals LLC | 15 | $226 |
Products named: VRAYLAR, REXULTI, Auvelity, CAPLYTA, ARISTADA, INGREZZA, Dyanavel XR, FANAPT.
Industry payments across MI — which companies pay providers there.
